UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial

Diabetes, obesity & metabolism, 2009-06, Vol.11 (6), p.611-622

2009

Volltextzugriff (PDF)

Efficacy of birinapant in combination with carboplatin in targeting platinum‑resistant epithelial ovarian cancers

International journal of oncology, 2022-03, Vol.60 (3), p.1, Article 35

2022

Volltextzugriff (PDF)

Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes

Diabetes, obesity & metabolism, 2008-05, Vol.10 (5), p.376-386

2008

Volltextzugriff (PDF)

Sustained 52‐week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes

Diabetes, obesity & metabolism, 2019-04, Vol.21 (4), p.883-892

2019

Volltextzugriff (PDF)

Efficacy and tolerability of saxagliptin compared with glimepiride in elderly patients with type 2 diabetes: a randomized, controlled study (GENERATION)

Diabetes, obesity & metabolism, 2015-07, Vol.17 (7), p.630-638

2015

Volltextzugriff (PDF)

Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment

Diabetes, obesity & metabolism, 2011-06, Vol.13 (6), p.523-532

2011

Volltextzugriff (PDF)

Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trial

Diabetes, obesity & metabolism, 2016-02, Vol.18 (2), p.186-190

2016

Volltextzugriff (PDF)

Efficacy and safety of saxagliptin compared with acarbose in Chinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: Results of a Phase IV open‐label randomized controlled study (the SMART study)

Diabetes, obesity & metabolism, 2017-11, Vol.19 (11), p.1513-1520

2017

Volltextzugriff (PDF)

Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks

Diabetes, obesity & metabolism, 2011-06, Vol.13 (6), p.567-576

2011

Volltextzugriff (PDF)

Impact of treatment with saxagliptin on glycaemic stability and β-cell function in the SAVOR-TIMI 53 study

Diabetes, obesity & metabolism, 2015-05, Vol.17 (5), p.487-494

2015

Volltextzugriff (PDF)

Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin

Archives of Endocrinology and Metabolism, 2018-08, Vol.62 (4), p.424-430

2018

Volltextzugriff (PDF)

Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin-based therapies

Diabetes, obesity & metabolism, 2016-12, Vol.18 (12), p.1253-1262

2016

Volltextzugriff (PDF)

Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR‐TIMI 53 outcome study

Diabetes, obesity & metabolism, 2017-07, Vol.19 (7), p.1045-1050

2017

Volltextzugriff (PDF)

Effect of VX‑765 on the transcriptome profile of mice spinal cords with acute injury

Molecular medicine reports, 2020-07, Vol.22 (1), p.33-42

2020

Volltextzugriff (PDF)

Effects of saxagliptin on β-cell stimulation and insulin secretion in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2011-09, Vol.13 (9), p.850-858

2011

Volltextzugriff (PDF)

Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis

Diabetes, obesity & metabolism, 2012-06, Vol.14 (6), p.481-492

2012

Volltextzugriff (PDF)

Impact of alanyl-glutamine dipeptide on severe acute pancreatitis in early stage

World journal of gastroenterology : WJG, 2008-01, Vol.14 (3), p.474-478

2008

Volltextzugriff (PDF)

Aspartate-ornithine granules in the treatment of nonalcoholic steatohepatitis: a multiple-dose parallel controlled clinical trial

Zhonghua gan zang bing za zhi, 2013-07, Vol.21 (7), p.528

2013

Volltextzugriff (PDF)

Saxagliptin: A New Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes

Cardiology in review, 2010-07, Vol.18 (4), p.213-217

2010

Volltextzugriff (PDF)

Ornithine aspartate and naloxone combined therapy for hepatic encephalopathy affects cognitive function, prognosis, and neuropeptide levels

Zhonghua gan zang bing za zhi, 2013-05, Vol.21 (5), p.385

2013

Volltextzugriff (PDF)

Study on L-Ornithine-L-Aspartate in the treatment of acute-on-chronic liver failure

Zhonghua gan zang bing za zhi, 2011-01, Vol.19 (1), p.63

2011

Volltextzugriff (PDF)

A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis

Chemistry & biology, 2012-09, Vol.19 (9), p.1142-1151

2012

Volltextzugriff (PDF)

Efficacy of parenteral glutamine in patients undergoing bone marrow transplantation

Nutrición hospitalaria : organo oficial de la Sociedad Española de Nutrición Parenteral y Enteral, 2012-01, Vol.27 (1), p.205-208

2012

Volltextzugriff (PDF)

Experimental 177Lu-PSMA-617 radioligand therapy in a patient with extended metastasized leiomyosarcoma

Nuklearmedizin. Nuclear medicine, 2019-08, Vol.58 (4), p.328

2019

Volltextzugriff (PDF)

Effect of glutamine on serum interleukin-8 and tumor necrosis factor-alpha levels in patients with severe pancreatitis

Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2008-01, Vol.28 (1), p.129

2008

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Aktive Filter

KollektionSage Journals

Nur zeigenGeprüft (Peer-Review)

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(28)

Publikationsform

Artikel
(66)

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Dipeptides - Therapeutic Use
(63)
Humans
(61)
Male
(54)
Middle Aged
(47)
Adult
(40)
Aged
(28)
Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Treatment Outcome
(18)
Adamantane - Analogs & Derivatives
(17)
Diabetes Mellitus, Type 2 - Drug Therapy
(17)
Double-Blind Method
(17)
Dipeptides - Administration & Dosage
(16)
Adamantane - Therapeutic Use
(15)
Endocrinology & Metabolism
(15)
Adolescent
(12)
Diabetes
(12)
Dipeptidyl-Peptidase Iv Inhibitors - Therapeutic Use
(12)
Drug Therapy, Combination
(11)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial

Efficacy of birinapant in combination with carboplatin in targeting platinum‑resistant epithelial ovarian cancers

Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes

Sustained 52‐week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes

Efficacy and tolerability of saxagliptin compared with glimepiride in elderly patients with type 2 diabetes: a randomized, controlled study (GENERATION)

Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment

Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trial

Efficacy and safety of saxagliptin compared with acarbose in Chinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: Results of a Phase IV open‐label randomized controlled study (the SMART study)

Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks

Impact of treatment with saxagliptin on glycaemic stability and β-cell function in the SAVOR-TIMI 53 study

Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin

Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin-based therapies

Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR‐TIMI 53 outcome study

Effect of VX‑765 on the transcriptome profile of mice spinal cords with acute injury

Effects of saxagliptin on β-cell stimulation and insulin secretion in patients with type 2 diabetes

Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis

Impact of alanyl-glutamine dipeptide on severe acute pancreatitis in early stage

Aspartate-ornithine granules in the treatment of nonalcoholic steatohepatitis: a multiple-dose parallel controlled clinical trial

Saxagliptin: A New Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes

Ornithine aspartate and naloxone combined therapy for hepatic encephalopathy affects cognitive function, prognosis, and neuropeptide levels

Study on L-Ornithine-L-Aspartate in the treatment of acute-on-chronic liver failure

A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis

Efficacy of parenteral glutamine in patients undergoing bone marrow transplantation

Experimental 177Lu-PSMA-617 radioligand therapy in a patient with extended metastasized leiomyosarcoma

Effect of glutamine on serum interleukin-8 and tumor necrosis factor-alpha levels in patients with severe pancreatitis

Aktive Filter

Suchergebnisse filtern